Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status

Journal of Epidemiology and Community Health

Volumn 57, Issue 9, 2003, Pages 730-733

  Jousilahti, P ^a   Salomaa, V ^a   Rasi, V ^b   Vahtera, E ^b   Palosuo, T ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; FIBRINOGEN;

CARDIOVASCULAR DISEASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE MARKER; FINLAND; HEALTH SURVEY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; SOCIOECONOMICS;

ACUTE-PHASE PROTEINS; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BODY CONSTITUTION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FIBRINOGEN; FINLAND; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RISK FACTORS; SERUM AMYLOID A PROTEIN; SMOKING; SOCIAL CLASS; SOCIOECONOMIC FACTORS;

EID: 0041317579     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.57.9.730     Document Type: Article

References (44)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993 (suppl K);14:12-16.
4. Tracy RP. Inflammation in cardiovascular disease. Circulation 1998;97:2000-2.
5. Kovanen PT, Mänttäri M, Palosuo T, et al. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch Intern Med 1998;158:1434-9.
6. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
7. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of novel Chlamydia, TWAR, with chronic coronary artery disease and acute myocardial infarction. Lancet 1988;ii:983-6.
8. Patel P, Mendall MA, Carrington D, et al. Associations of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-14.
9. Mattila KJ, Nieminen MS, Valtonen W, et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-81.
10. McDonald K, Rector TS, Braulin EA, et al. Cytomegalovirus disease link to coronary artery disease. Am J Cardiol 1989;64:359-62.
11. Roivainen M, Alfthan G, Jousilahti P, et al. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 1998;98:2534-7.
12. Nieto FJ, Sorlie P, Comstock GW, et al. Cytomegalovirus infection, lipoprotein (a), and hypercoagulability: an atherogenic link. Arterioscler Throm Vasc Biol 1997;17:1780-5.
13. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsburg Cohort study, 1984 to 1992. Circulation 1999;99:237-42.
14. Kuller LH, Tracy RP, Shaten J, et al. (for the MRFIT Research Group). Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-47.
15. Ernst E, Resch K. Fibrinogen as cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-63.
16. Thompson SG, Kienast J, Pyke SDM, et al. Hemostatic factors and risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635-41.
17. Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993;102:131-46.
18. Kisilevsky R, Lindhorst E, Ancsin JB, et al. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: a hypothesis. Int J Exp Clin Invest 1996;3:252-60.
19. Jousilahti P, Salomaa V, Rasi V, et al. The association of C-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease - baseline findings of the PAIS project. Atherosclerosis 2000;156:451-6.
20. Valkonen T. Trends in regional and socio-economic mortality differentials in Finland. Int J Health Sci 1992;3:157-66.
21. Kunst AE, Mackenbach JP. The size of mortality differences associated with educational level in nine industrialized countries. Am J Public Health 1994;84:932-7.
22. Kunst AE, Mackenbach JP. International variation in the size of mortality differences associated with occupational status. Int J Epidemiol 1994;23:742-50.
23. Wilson TW, Kaplan GA, Kauhanen J, et al. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study. Am J Epidemiol 1993;137:292-300.
24. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995;141:1117-27.
25. Clauss A. Gerinnungsphysiologische Schnell Methode zur Bestimmung des Fibrinogens. Acta Haemal 1957;17:237-46.
26. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation 1999;100:96-102.
27. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-72.
28. Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular risk factors: a population-based cross-sectional study. BMJ 1996;312:1061-5.
29. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
30. Langrand WK, Niessen HW, Wolbink GJ, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997;95:97-103.
31. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11.
32. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
33. Fyfe AL, Rothenberg LS, DeBeer FC, et al. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic process. Circulation 1997;96:2914-19.
34. Pekkanen J, Tuomilehto J, Uutela A, et al. Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ 1995;311:589-93.
35. Yudkin JS, Stenouwer CDA, Emeis JJ, et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8.
36. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183-6.
37. Ernst E. The Role of fibrinogen as cardiovascular risk factor. Atherosclerosis 1993;100:1-12.
38. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coranary heart disease. Heart 1997;78:273-7.
39. Feghali CA, Wright TM. Cytokines and acute and chronic inflammation. Front Biosci 1997;2:12-26.
40. Cohere MC, Cohen S. Cytokine function: a study in biologic diversity. Am J Clin Pathol 1996;105:589-98.
41. Danesh J, Muir J, Wong YK, et al. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 1999;20:954-9.
42. Iso H, Shimamoto T, Sato T, et al. Passive smoking and plasma fibrinogen concentrations. Am J Epidemiol 1996;144:1151-4.
43. Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938-41.
44. Martyn CN, Meade TW, Stirling Y, et al. Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra-uterin growth. Br J Haematol 1995;89:142-6.